Bioinformatics Collaboration and Licensing Deals 2019-2024

$3,995.00

Bioinformatics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024

Publication date
November 2024
Number of pages
450+
Product type
Research report
Available formats
PDF document
Report edition
6
SKU
CP2111

Bioinformatics Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the bioinformatic deals entered into by the world's leading biopharma companies.

Fully revised and updated, the report provides details of bioinformatic deals from 2019 to 2024.

The report provides a detailed understanding and analysis of how and why companies enter bioinformatic deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. 

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 899 bioinformatic deals announced since 2019 including financial terms where available including links to online deal records of actual bioinformatic partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of bioinformatic dealmaking. 

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in bioinformatic dealmaking since 2019.

Chapter 3 provides an overview of the leading bioinformatic deals since 2019. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in bioinformatic dealmaking with a brief summary followed by a comprehensive listing of bioinformatic deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of bioinformatic deals signed and announced since Jan 2019, where a contract document is available in the public domain. 

Chapter 6 provides a comprehensive and detailed review of bioinformatic partnering deals signed and announced since Jan 2019. The chapter is organized by specific bioinformatic technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in bioinformatic deal making since 2019.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Bioinformatic Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2019
•    Browse bioinformatic collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Report scope

Bioinformatic Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of bioinformatic trends and structure of deals entered into by leading biopharma companies worldwide.

Bioinformatic Collaboration and Licensing Deals includes:
•    Trends in bioinformatic dealmaking in the biopharma industry
•    Directory of bioinformatic deal records covering pharmaceutical and biotechnology
•    The leading bioinformatic deals by value
•    Most active bioinformatic licensing dealmakers

Bioinformatic Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

•    What are the precise rights granted or optioned?
•    What is actually granted by the agreement to the partner company?
•    What exclusivity is granted?
•    What is the payment structure for the deal?
•    How are sales and payments audited?
•    What is the deal term?
•    How are the key terms of the agreement defined?
•    How are IPRs handled and owned?
•    Who is responsible for commercialization?
•    Who is responsible for development, supply, and manufacture?
•    How is confidentiality and publication managed?
•    How are disputes to be resolved?
•    Under what conditions can the deal be terminated?
•    What happens when there is a change of ownership?
•    What sublicensing and subcontracting provisions have been agreed?
•    Which boilerplate clauses does the company insist upon?
•    Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
•    Which jurisdiction does the company insist upon for agreement law?

Bioinformatics Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2019
•    Browse bioinformatic collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in bioinformatic dealmaking
2.1. Introduction
2.2. Bioinformatic deals over the years
2.3. Most active bioinformatic dealmakers
2.4. Bioinformatic deals by deal type
2.5. Bioinformatic deals by therapy area
2.6. Bioinformatic deals by industry sector
2.7. Deal terms for bioinformatic deals
2.7.1 Bioinformatic deals headline values
2.7.2 Bioinformatic deal upfront payments
2.7.3 Bioinformatic deal milestone payments
2.7.4 Bioinformatic royalty rates

Chapter 3 – Leading bioinformatic deals
3.1. Introduction
3.2. Top bioinformatic deals by value

Chapter 4 – Most active bioinformatic dealmakers
4.1. Introduction
4.2. Most active bioinformatic dealmakers
4.3. Most active bioinformatic deals company profiles

Chapter 5 – Bioinformatic contracts dealmaking directory
5.1. Introduction
5.2. Bioinformatic contracts dealmaking directory

Chapter 6 – Bioinformatic dealmaking by technology type

Deal directory

Deal directory – Bioinformatic deals by company A-Z
Deal directory – Bioinformatic deals by deal type
Deal directory – Bioinformatic deals by therapy area

Deal type definitions

About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering



Table of figures

Figure 1: Bioinformatic deals since 2019
Figure 2: Active bioinformatic dealmaking activity – 2019 - 2024
Figure 3: Bioinformatic deals by deal type since 2019
Figure 4: Bioinformatic deals by therapy area since 2019
Figure 5: Bioinformatic deals by industry sector since 2019
Figure 6: Bioinformatic deals with a headline value
Figure 7: Bioinformatic deals with an upfront value
Figure 8: Bioinformatic deals with a milestone value
Figure 9: Bioinformatic deals with a royalty rate value
Figure 10: Top bioinformatic deals by value since 2019
Figure 11: Most active bioinformatic dealmakers 2019 - 2024
Figure 12: Bioinformatic deals by technology type since 2019

 

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $7,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

2bPrecise, 3Sixty, 4bases, 4P-Pharma, 23andMe, 111, A3 Informatics, Abbott Laboratories, Abbvie, Abiosciences, ABL Diagnostics, ABX-CRO Advanced Pharmaceutical Services, Accelerated Enrollment Solutions, Accelq, Accenture, AccessDx Laboratory, Acclinate, Accuray, AccuWeather, Acentrus Specialty, Actigraph, Acumen Analytics, Ada Health, Adaptive Biotechnologies, Adaptive Research, ADAS 3D Medical, Adhera Therapeutics, AdhereHealth, Adva Biotechnology, Advanced Biological Laboratories, Advanced Chemistry Development, Advanced Clinical, Advantech, Advanz Pharma, Advarra, AESOP Technology, Aether, Aetion, Aetna, Aetos Pharma, Aevolve, Afero, Agilent Technologies, AIBody, AiCure, Aidoc, Aiforia Technologies, AirXpanders, Akerna, Akili Interactive Labs, Aktana, Albert Einstein College of Medicine, Alector, Alex Therapeutics, Alimentiv, Alira Health, Allelica, Allergan, Allied Digestive Health, Allosteric Bioscience, Alloy Therapeutics, Allscripts, AllyAlign Health, Almac Group, Almirall, Alpenglow Biosciences, Alpha Tau Medical, AltMed Florida, Altoida, Alto Neuroscience, Alyvant, Alzheimer's Drug Discovery Foundation, Amazon Web Services, Amber Pharmacy, AMD Insight, American Academy of Neurology, American Association for the Study of Liver Diseases, American College of Cardiology, American Heart Association, American Medical Association, American Society of Hematology, American Type Culture Collection (ATCC), Amgen, Amici Pharmaceuticals, Amplifire, Amylyx Pharmaceuticals, Analytical BioSciences, Ancestry, AnchorDx, Andelyn Biosciences, Andor Technology, Andrew Alliance, ANI Pharmaceuticals, Anju Software, Ansys, Anthem, Anumana, Apollo Health, AppBus, Apple, Applied BioMath, Applied DNA Sciences, AppliedVR, Apricity Health, Aptar Pharma, Arcade Therapeutics, Arc Bio, Ares Genetics, Arima Genomics, Aris Global, Arkos Health, Arria, Artificial, ArtiQ, Asa Ren, Asensus Surgical, Asimily, Aslan Pharma, Aspen Imaging Healthcare, Aspen Neuroscience, Astellas Pharma, AstraZeneca, AtCor Medical, Athenahealth, ATMPS, Atomica.ai, ATUM, Aural Analytics, Autism Learning Partners, Autolomous, Auxita, Avalere Health, Avantor, Avera Health, Awakn Life Sciences, Axial3D, Basepair, BASF, Baszucki Brain Research Fund, Bausch & Lomb, Baxter International, Bayer, Baylor College, Baylor College of Medicine, BCG Digital Ventures, BC Platforms, B dot Medical, Be-ys, Be Biopharma, Becton Dickinson, BeeKeeperAI, BehaVR, BeiGene, Belle.ai, Benchling, BenevolentAI, Berry Genomics, Better Therapeutics, BGI, Bialogics, Biedermann Motech, Bill and Melinda Gates Foundation, Bio-Rad Laboratories, Bio.logis Genetic Information Management, BioBam Bioinformatics, BioBright, BioCentriq, BioClinica, Biodesix, Bioforum, Biofourmis, Biogen, Biognosys, Bioinfogate, BioIntelliSense, BioLizard, Biological Dynamics, Biolojic Design, bioMerieux, Biomodex, Bionik Laboratories, BioPharmics, Biosero, BioSolveIT, BioSymetrics, Biotricity, Bioz, Bird Foundation, Blackford, Blue Note Therapeutics, BlueRock Therapeutics, Blue Water Biotech, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Boston Cell Standards, BostonGene, Boston Scientific, Boston University, BPGbio, Brain Balance Achievement Centers, BrainLAB, Brainomix, Bridge Biotherapeutics, Bright Giant, BrightInsight, Bright Minds Biosciences, BrightView Health, Bristol-Myers Squibb, Broad Institute, Brooks Life Science Systems, BSG Analytics, BYG4lab, BYOMass, Calyx, Cambridge Brain Sciences, Cambridge Cognition, Cambridge Quantum Computing, CamDiab, Canada House Wellness Group, Canadian Armed Forces, Canadian Council, Canadian Neuromuscular Disease Registry, Cancer and Blood Specialty Clinic, CancerCare, Cancer Genetics, Cannabis OneFive, CannAcubed, Cantel Medical, Cara Care, Cardinal Health, CareDox, CareDx, CareEvolution, Carepay, Caresyntax, CareTaker Medical, Caris Life Sciences, Carlsmed, Casetabs, Castle Biosciences, Castor, CB2 Insights, CDISC, Cegedim, Celemics, Celgene, CellCarta, Cellipont Bioservices, Censis Technologies, Center for Drug Evaluation and Research, Centers for Disease Control and Prevention, Centogene, Centre Leon Berard, Cerebral, Cerner, Cerner Enviza, Certara, Certintell, Certis Oncology Solutions, Champions Oncology, CHAMPS Oncology, Charite-Universitatsmedizin, Charite Universitatsmedizin Berlin, CHARM Therapeutics, ChemAxon, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Michigan Foundation, Cholangiocarcinoma Foundation, Chonnam National University, Chronicled, Chronolife, Chugai Pharmaceutical, Ciitizen, Cincinnati Children’s Hospital Medical Center, Ciox Health, Cipher Skin, CirrusMD, Clario, Claritas HealthTech, Clarivate Analytics, Clarix, CLEAR, ClearPoint Neuro, Cleveland Clinic, Click Therapeutics, Client Outlook, Clinical Research Strategies, CliniFusion, ClinOne, Closed Loop Medicine, CMIC, CoBTeK, Code Ocean, Cognizant, Cognoa, CogState, Columbia University, Companion Medical, Complete Genomics, Comprehend Systems, Compugen, Compumed, ConcertAI, Concord Medical Services Holdings, Cooper Aerobics, COPD Foundation, CorePlus, Corrona, COTA, Crothall Healthcare Technology Solutions, Crown Bioscience, Culture Biosciences, Curebase, CureMatch, CureMD, CureMetrix, Cures Within Reach, CureVac, Curio Bioscience, Curis, Curium, CVS Caremark, Cybeats Technologies, Cyclica, Cynergi Health Partners, Cynerio, Cytiva, CytomX Therapeutics, D-Wave Quantum, DarioHealth, DarwinHealth, Datavant, Datos Health, DaVita, Dawn Health, DEARhealth, Debiopharm, Decode Health, Dedalus Group, Deep Cube, Deep Lens, Definition Health, Delve Health, DemDx, Deontics, DePuy, Dermalog, DexCom, DiA Imaging Analysis, Digital Diagnostics, Digital Therapeutics Alliance, Discngine, Divergence Neuro Technologies, Diversified, DNAnexus, DNA Script, Domo, Dotmatics, Dotphoton, DP Clinical, Drake University, Duke University, Dutch SAZ, DxS, E25Bio, Eagle Genomics, EatLove, EBSCO Information Services, EchelonDx, eClinicalHealth, Ehave, Eisai, Elanco, Elemental Machines, Eleven Biotherapeutics, Eli Lilly, Elsevier, Elucidata, Embleema, EMD Serono, Emerald Innovations, Emocha Mobile Health, Emsere, Enamine, Encoda, EncrypGen, endpoint Clinical, Enosis Therapeutics, ENPICOM, Entheon Biomedical, Envision Pharma Group, Epic, Epilepsy Foundation (EF), Epivax, Equicare Health, Erlangen University Hospital, ERT, EtectRx, Etiometry, Euformatics, Eureka Eurostars, European Board and College of Obstetrics and Gynaecology, European Innovation Council, European Molecular Genetics Quality Network, European Union, Eversana, Evidation Health, EvidNet, Evosep, Evotec, eWellness Healthcare, Exabel, Exactis Innovation, Excelra, Exostar, Fabric Genomics, FatiAbGen, FEops, Ferring Pharmaceuticals, Fio, Firefly Neuroscience, FitBit, FitOn, FK LiveLabs, Flagship Biosciences, Flatiron Health, Flo Health, Flow Pharma, FluidAI Medical, Fluidigm, Flywheel, Food and Drug Administration (FDA), Forian, Formation Bio, Foundation Fighting Blindness, Foundation Medicine, Freespira, Fujitsu Laboratories, Fujitsu Laboratories of America, G-Con, G3 Therapeutics, G42 Healthcare, Gaia, Galatea Bio, Galderma, GAVI Alliance, GEDmatch, GE Healthcare, Geisinger Health System, GeneData, GeneDX, Geneial, Genentech, Genesis Research and Development, Genestack, Genetic Analysis, Geneva University Hospitals, Geneyx, GenNext Technologies, Genome Insight, Genome Medical, Genomill Health, Genoox, Genosity, Georgian Bay General Hospital, German Heart Centre Berlin, Gero, Gerresheimer, Gestalt Diagnostics, Gevity Consulting, Ginkgo BioWorks, GI Reviewers, Glassbeam, Glemser Technologies, Glimpse Group, Global Genes, GlobalLogic, Glooko, Glytec, G Medical Innovations, GN Group, GNS Healthcare, GO2 Foundation for Lung Cancer, GoodRx, Google, GrayMatters Health, GreenLeaf Genetics, GSK, Guardant Health, H1, Hadassah Medical Center, Halo Dx, Halo Labs, Hamad Medical, Hamamatsu Photonics, Hannover Medical School, Hapbee Technologies, Happify Health, Harvard University, HashedIn, HCA Healthcare, HCL Technologies, HealthCore, Health Gorilla, HealthSnap, HealthSteps, Health Vector, HealthVerity, Healthy.io, HeartBeam, Hematology-Oncology Associates of Central New York, Henan Cancer Hospital, Henry Schein, Hermes Medical Solutions, Hillstream BioPharma, Hitachi High-Technologies Corporation, Holmusk, Holo4Labs, Horizon Europe, HP, HSBlox, HSTpathways, HTG Molecular Diagnostics, Huami, Huma, Humana, Human API, Human Cell Atlas, Hyfe, I-Dante, Ibex Medical Analytics, IBM, IBM Watson Health, iCAD, Icahn School of Medicine at Mount Sinai, ICAN, Icometrix, Icon, IDBS, IDnow, Igentify, IgniteData, Ikonopedia, Iktos, Illumina, ImageBiopsy Lab, ImageMover, Imagia Cybernetics, Imaware, ImmersiveTouch, Immunocore, ImmunoPrecise Antibodies, Imprivata, INBRAIN Neuroelectronics, Incannex Healthcare, Indegene Lifesystems, Indiana University, Indica Labs, Indivumed, IndyGeneUS AI, InfoBionic.Ai, InfoChem, Infor, inHEART, INNERVIA Bioelectronics, Innoplexus, InnovaQor, Innovate UK, Innovative Research, Innovent Biologics, Inscopix, InsightRX, Insilico Biotechnology, InSilicoTrials, InsiteOne, Inspirata, Inspira Technologies, Institut Gustave Roussy, Intabio, Integra Connect, Integra LifeSciences, Intelligence Advanced Research Projects Activity (IARPA), Intelligencia, Intelliware Development, Intermountain Healthcare, International Flavors and Fragrances, International Niemann-Pick Disease Registry, International Spine Study Group Foundation, Intouch Group, InTouch Health, Invaryant, Invenio Imaging, Invitae, InVivoScribe, Ionian University, IQVIA, iReceptor Plus, iRxReminder, Iterative Scopes, iXensor, Janssen Biotech, Janssen Pharmaceuticals, Janssen Research & Development, Japan Tobacco, JASE Health, Jayne Koskinas Ted Giovanis Foundation for Health and Policy, Jazz Pharmaceuticals, Jefferson Healthcare, Jewish General Hospital, Jhpiego, Jianming Pharmaceutical, Joerns Healthcare, Johns Hopkins University, John Snow, Johnson & Johnson, Jolly Good, JSR Life Sciences, Juniper Investment Company, Kaiku Health, Karolinska Institute, KeyWise, Kinesiometrics, Kingdee Software Group, Kings College London, KiOmed Pharma, Kite Pharma, Klue, Kno2, Komodo Health, Kore, KT Corporation, Kumanu, Kvantify, KVS Technologies, L7 Informatics, Labguru, Laboratory Corporation of America, Laboratory of Pathology, LabTwin, LabVantage Solutions, LabVoice, La Jolla Institute for Allergy & Immunology, Lambda Therapeutics, LANGaware, Lawrence Livermore National Laboratory, Leal Health, Leica Biosystems, LEO Pharma, Les Laboratoires Servier, Levelblox, Levrx Technology, Lifebit Biotech, Life Image, LifeOmic, LifeScan, Lifespin, Lightbeam Health Solutions, Lightship, Limbix, Lirio, Litesprite, Lochan, Lokavant, Longeveron, Loopback Analytics, Lord Global, Lotus Clinical Research, Lovell Government Services, LSU Health Sciences Center, Luca Healthcare, LUCID, Lumanity, Lung Cancer Foundation of America, Lung Cancer Initiative, LUNGevity Foundation, Lunit, Lupus Foundation of America (LFA), Lykan Bioscience, Lynx.MD, M2Gen, Macao Kiang Wu Hospital, Magic Leap, Mainz Biomed, Mandos, Mapi, Masimo, Massachusetts General Hospital, Mass General Brigham, Massive Bio, MasterControl, Maxcyte, Maya Medical, Mayo Clinic, MC10, McCreadie Group, McGill University, McKesson, McLean Hospital, MD Anderson Cancer Center, MDClone, MD Matrix, Medable, Medcase, MedEvoke, Medgate, Medial EarlySign, Medicago, Medical Guardian, Medical Microinstruments, Medical Tracking Solutions, Medical University of Graz, Medicom, Medidata Solutions, MediKarma, Medipath, Medis Medical Imaging, Medistics, MEDITECH Greenfield, MediTechnix, Medivizor, Medline Industries, MedMine, MedNet Solutions, Medpace, Medpod, MedRhythms, Medtronic, Melax Technologies, Memorial Sloan Kettering Cancer Center, MemVerge, Merck and Co, Merck KGaA, Meru Health, Metaverse Standards Forum, Mettler Toledo, MGI Tech, MiCare Path, Michael J Fox Foundation, Microba Life Sciences, MicroBiome Therapeutics, Microsoft, MiLaboratories, MILA International, Miltenyi Biotec, MIM Software, Mind Cure Health, MindMaze, Mind Medicine, MindPeak, Minnesota Multistate Contracting Alliance for Pharmacy, Mirada Medical, Mission Bio, MITRE, Mitsubishi Tanabe Pharma, MMS, Moderna, Molecular Health, Molecular Instruments, Monash University, Montreal Heart Institute, MORE Health, Movendo Technology, MoveUP, MPECT, MphRx, MSAID, Mydecine Group, MyMeds & Me, Myndshft, MyndVR, myNEO, MyoKardia, Myriad Genetics, Nankai Hospital, Nano-X Imaging, NanoString Technologies, Nashville Biosciences, Natera, National Cancer Care Alliance, National Cancer Center of Japan, National Cancer Institute, National Cerebral and Cardiovascular Disease Research Center, National Healthcare Services (NHS), National Health Service, National Institute for Health and Care Excellence, National Institute of Biomedical Imaging and Bioengineering, National Institute of Mental Health, National Institute on Aging, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Organization for Rare Disorders, Nautilus, Nebraska Medicine, Nebula Genomics, NEC, Nektar Therapeutics, Neo7Bioscience, Neogenomics, Neosoma, NE Scientific, NeuPath Health, NeuroLex Laboratories, Neurolief, NeuroScience Associates, NeuroSigma, NeuroTracker, Newel Health, New England Biolabs, New York Presbyterian/Columbia, NextGate, Next Gen Diagnostics, Ninety One, NinthBio, Noldus Information Technology, Noom, Normunity, Northeastern University, Northwell Health, Norwegian University of Science, Novadiscovery, Novarad, Novartis, Novigenix, Novo Nordisk, Novotech, NRG Oncology, NTT Data, NTT Medical Center Tokyo, Nuance Healthcare, Nuvo Group, Nvidia, Nyansa, ObvioHealth, Ochsner Health System, OKKO Health, Olympus, OmiCure, OMNY Health, OncoBay Clinical, OncoCyte, Oncode Institute, OncoDNA, OncoImmunity, OncologyInformationService, Oncology Pharma, Oncology Research Information Exchange Network, OncoMyx Therapeutics, One Drop, One GI, OnMed, Ono Pharmaceutical, Ontada, ONWARD Medical, Onymos, OpenAI, OpenEye Scientific Software, Open Source Imaging Consortium, Optac-X, Optibrium, OptraHEALTH, OptraSCAN, OPUM, Oracle, Oracle Health Sciences, Orbis, Orexo, OrganX, Ori Biotech, OrigiMed, Orion, OSE Immunotherapeutics, Ospedale Pediatrico Bambino Gesu, Otsuka, Overland Pharmaceuticals, Owkin, Oxford BioMedica, Oxford Nanopore Technologies, P-Chip, Pacific Biosciences, Paige, Palantir, Palatin Technologies, Palisade Bio, Pangea, Paradigm, Paragon Bioservices, Parexel, PARI, Parvizi Surgical Innovation, Pasithea Therapeutics, PathAI, PathKeeper Surgical, Pathway Solutions, PatientBond, PatientFi, PEAR Therapeutics, Penn Medicine, PeptiDream, PercayAI, PetaGene, Pfizer, Pharmacelera, Pharmanovia, Pharmarack, PhoreMost, Phreesia, Phylloceuticals, PhysIQ, PicnicHealth, Pieces Technologies, PierianDx, Pillar Biosciences, Pilloxa, PINC AI Applied Sciences, Piur Imaging, Plecosystems, Plume Labs, PointClickCare Technologies, PolarisQB, Popit, PostEra, PPD, PRA Health Sciences, PreciseDx, Precision Digital Health, Precision Health Informatics, PrecisionOS, Predictmedix, Prelude Therapeutics, Premier Health Group, Premier Inc, Premier Research, Prenosis, Primetime Medical Software, ProAssurance, Procter & Gamble, Prognos, ProMedica Clinical Research Center, Prometheus Biosciences, Prometheus Laboratories, ProofPilot, Proprio, Prospection, Protein Metrics, ProteoMediX, Protocol First, Proton Therapy, Proximie, Psychedelic Society Belgium, Pulse Infoframe, Q-State Biosciences, Q2 Solutions, QDX, QIAGEN, QMed Innovations, QuadMed, Quadram Institute, QuantHealth, Quantinm, Quantiphi, Quest Diagnostics, QuidelOrtho, QurAlis, Quris-AI, R3, Rad AI, Radformation, RadNet, RARE-X, RaySearch Laboratories, Readout Health, Real Time Medical, Rebus Biosystems, Recover Together, RecoveryOne, Recursion, Redenlab, Redesign Science, Redox, RefleXion Medical, Regard, Regenstrief Institute, Relay Medical, RelianceHMO, Reputable Health, Research Council of Norway, Research Institute of McGill University Health Centre (RI MUHC), RetroBrain, Revitalist Lifestyle and Wellness, Ribera Solutions, Ro, Roche, Roche Diagnostics, Rocket VR Health, Rockley Photonics, RockStep Solutions, Rohto Pharmaceutical, Rosalind, Roswell Park Cancer Institute, Rouumtech, Roux Institute, Royal Philips Electronics, Rune Labs, Rush University Medical Center, Rx.Health, RxCloud, Rymedi, S12 Solutions, Saama, Sage Bionetworks, SalesForce, Samsung Electronics, SandboxAQ, Sandoz, Sanguina, Sanofi, Santen Pharmaceutical, Saphetor, Sartorius, SAS, Satisfai Health, Savana, Sawai Pharmaceuticals, Scale Biosciences, Scanwell Health, Schenker Technologies, Schrodinger, SciBite, Science 37, Sciex, Scignyte, Scilligence, Scitara, Select Rehabilitation, Self Care Catalysts, Sema4, Sensyne Health, Seqster, Serokell, Sheba Medical Center, Shionogi, Siemens Healthineers, SightCall, Sigma Computing, Signant Health, SilverCloud Health, SimBioSys, Simons Searchlight, Simulations Plus, Singleron Biotechnologies, Singular Genomics Systems, SkylineDX, Slovak University of Technology, smartShift, Smith & Nephew, Snowflake, Sodexo Healthcare, SoftBank, SOPHiA Genetics, SOTERIA Precision Medicine Foundation, Spartan Medical, Spectrum Dynamics, Spesana, Sphere Health, Spire Health, St. Lukes Health System Clinically Integrated Providers, Stago, Stallergenes Greer, Stanford University School of Medicine, StarFish Medical, StemoniX, Stereotaxis, Stevenson Memorial Hospital, Stony Brook University, Strand Life Sciences, Structura Biotechnology, Sumitomo Dainippon Pharma, Summus, Sunovion Pharmaceuticals, Surfacide, Surgical Notes, Surgical Theater, Susan G. Komen for the Cure, Swinburne University, Syapse, Syneos Health, Syntegra, Syntellis Performance Solutions, SyntheticMR, Tabula Rasa HealthCare, Tachyum, Takeda Pharmaceutical, TALi, Taliaz, Talis Biomedical, TapestryHealth, Target RWE, Tealium, Techcyte, Teijin, TeleVet, Telix Pharmaceuticals, Temedica, Temple Health, Tempus, Tenet Healthcare, TeraRecon, Terran Biosciences, Terumo Cardiovascular Systems, TeselaGen, Tetra Pharm Technologies, TetraScience, Teva Pharmaceutical Industries, Texas Oncology, TFS International, TheraCann International Benchmark, Therma Bright, Thermo Fisher Scientific, The University of Chicago Medicine, THINK Surgical, Thomas Jefferson University, Thuasne and Townsend Design, Tilak Healthcare, Tissue Analytics, TMA Precision Health, TMM Software, Todos Medical, Tokyo Institute of Technology, Total Brain, TPT Global Tech, Translational Software, Trialbee, Trialogics, TrialSpark, Tribun Health, TriNetX, Trinity Biotech, Trinity Life Sciences, Trio Healthcare, Triple Ring Technologies, TruDiagnostic, Truveta, Twist Bioscience, Uberdoc, Ubirch, UCB, Ultima Genomics, uMotif, Universite Laval, University College London, University Hospitals Ventures, University Medical Center Utrecht, University of Auckland, University of Basel, University of California Los Angeles, University of California San Francisco, University of Liverpool, University of Maryland School of Medicine, University of Massachusetts, University of Montreal, University of Nagasaki, University of New South Wales, University of Oslo, University of Oxford, University of Pittsburgh, University of Quebec, University of Rennes, University of Sherbrooke, University of Texas, University of Texas Health Science Center at Houston, University of Tokyo, University of Tubingen, University of Vermont, University of Virginia, Unlearn, UNO Technologies, UpScriptHealth, Upside Health, UpToDate, Us2.ai, UV Partners, UW Medicine, Vaica Medical, Valent Biosciences, ValGenesis, Validic, Valo Health, Vanderbilt University, Vanguard Scientific Systems, Vapotherm, Varian Medical Systems, Vault Health, VeChain, VeeMed, Veeva Systems, VELL Health, Velsera, Ventech, Veradigm, Verana Health, Verantos, VeraSci, Verge Genomics, Verily, Verinetics, Verogen, Versus Systems, Veta Health, VetNOW, Vibrent Health, Vicarious Surgical, Vicore Pharma, Vidscrip, VieCure, ViewMind, Vineti, Virgo Surgical Video Solutions, VirtaMed, Visiopharm, Visotec, VistaPath, Vita Global Sciences, VitalHub, VitalTech, Vithas Group, Vivante Health, vivoPharm, VivoSense, Vivus, Viz.ai, Vocalis Health, Voicebrook, Volastra Therapeutics, Voluntis, VoxNeuro, Washington University in St Louis, WCG Trifecta, WeComput, Weill Cornell Medical College, WekaIO, Wellcome Trust, Wellcome Trust Sanger Institute, WellDoc, Wellframe, Wellthy Therapeutics, Whiterabbit, Winnipeg Regional Health Authority, WinterLight Labs, Wise Therapeutics, Withings, Woom, Wylder Nation Foundation, Xandar Kardian, xCures, XRHealth, Yale School of Medicine, Ypsomed, Zealand Pharma, Zebra Medical Vision, Zelgen, Zenovative, Zepp Health, Zoetis, Zoic Labs, Zoll Medical, Zollner, ZS, Zyter

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!